411 related articles for article (PubMed ID: 25748073)
21. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry.
Perlis RH; Perlis CS; Wu Y; Hwang C; Joseph M; Nierenberg AA
Am J Psychiatry; 2005 Oct; 162(10):1957-60. PubMed ID: 16199844
[TBL] [Abstract][Full Text] [Related]
22. Large clinical trials in epilepsy: funding by the NIH versus pharmaceutical industry.
Privitera M
Epilepsy Res; 2006 Jan; 68(1):52-6. PubMed ID: 16377139
[TBL] [Abstract][Full Text] [Related]
23. A cross-sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design.
Goswami ND; Tsalik EL; Naggie S; Miller WC; Horton JR; Pfeiffer CD; Hicks CB
Trials; 2014 Jan; 15():31. PubMed ID: 24450313
[TBL] [Abstract][Full Text] [Related]
24. The association of funding source on effect size in randomized controlled trials: 2013-2015 - a cross-sectional survey and meta-analysis.
Falk Delgado A; Falk Delgado A
Trials; 2017 Mar; 18(1):125. PubMed ID: 28292317
[TBL] [Abstract][Full Text] [Related]
25. Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis.
Khan NA; Lombeida JI; Singh M; Spencer HJ; Torralba KD
Arthritis Rheum; 2012 Jul; 64(7):2059-67. PubMed ID: 22275179
[TBL] [Abstract][Full Text] [Related]
26. Impact of industry collaboration on randomised controlled trials in oncology.
Linker A; Yang A; Roper N; Whitaker E; Korenstein D
Eur J Cancer; 2017 Feb; 72():71-77. PubMed ID: 28027518
[TBL] [Abstract][Full Text] [Related]
27. Noninferiority is (too) common in noninferiority trials.
Soonawala D; Dekkers OM; Vandenbroucke JP; Egger M
J Clin Epidemiol; 2016 Mar; 71():118-20. PubMed ID: 26607238
[No Abstract] [Full Text] [Related]
28. Industry Collaboration and Primary Guest Authorship of High-Impact Randomized Clinical Trials: A Cross-Sectional Study.
Roper N; Korenstein D
J Gen Intern Med; 2015 Oct; 30(10):1421-5. PubMed ID: 25832619
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and factors associated with use of placebo control groups in randomized controlled trials in psoriasis: a cross-sectional study.
Katz KA; Karlawish JH; Chiang DS; Bognet RA; Propert KJ; Margolis DJ
J Am Acad Dermatol; 2006 Nov; 55(5):814-22. PubMed ID: 17052487
[TBL] [Abstract][Full Text] [Related]
30. Industry sponsorship and authorship of clinical trials over 20 years.
Buchkowsky SS; Jewesson PJ
Ann Pharmacother; 2004 Apr; 38(4):579-85. PubMed ID: 14982982
[TBL] [Abstract][Full Text] [Related]
31. Noninferiority is almost certain with lenient noninferiority margins.
Flacco ME; Manzoli L; Ioannidis JP
J Clin Epidemiol; 2016 Mar; 71():118. PubMed ID: 26607237
[No Abstract] [Full Text] [Related]
32. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study.
Turner K; Carboni-Jiménez A; Benea C; Elder K; Levis B; Boruff J; Roseman M; Bero L; Lexchin J; Turner EH; Benedetti A; Thombs BD
BMJ Open; 2020 May; 10(5):e035633. PubMed ID: 32398334
[TBL] [Abstract][Full Text] [Related]
33. Discontinuation and Nonpublication of Randomized Clinical Trials Conducted in Children.
Pica N; Bourgeois F
Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27492817
[TBL] [Abstract][Full Text] [Related]
34. Financial ties of principal investigators and randomized controlled trial outcomes: cross sectional study.
Ahn R; Woodbridge A; Abraham A; Saba S; Korenstein D; Madden E; Boscardin WJ; Keyhani S
BMJ; 2017 Jan; 356():i6770. PubMed ID: 28096109
[TBL] [Abstract][Full Text] [Related]
35. Randomized trials assessing calcium supplementation in healthy children: relationship between industry sponsorship and study outcomes.
Nkansah N; Nguyen T; Iraninezhad H; Bero L
Public Health Nutr; 2009 Oct; 12(10):1931-7. PubMed ID: 19254426
[TBL] [Abstract][Full Text] [Related]
36. [Controlled randomized clinical trials].
Jaillon P
Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
[TBL] [Abstract][Full Text] [Related]
37. Association between research sponsorship and study outcome in plastic surgery literature.
Momeni A; Becker A; Bannasch H; Antes G; Blümle A; Stark GB
Ann Plast Surg; 2009 Dec; 63(6):661-4. PubMed ID: 19887933
[TBL] [Abstract][Full Text] [Related]
38. Association of Industry Sponsorship With Outcomes of Nutrition Studies: A Systematic Review and Meta-analysis.
Chartres N; Fabbri A; Bero LA
JAMA Intern Med; 2016 Dec; 176(12):1769-1777. PubMed ID: 27802480
[TBL] [Abstract][Full Text] [Related]
39. Assessing the Justification, Funding, Success, and Survival Outcomes of Randomized Noninferiority Trials of Cancer Drugs: A Systematic Review and Pooled Analysis.
Gyawali B; Tessema FA; Jung EH; Kesselheim AS
JAMA Netw Open; 2019 Aug; 2(8):e199570. PubMed ID: 31469391
[TBL] [Abstract][Full Text] [Related]
40. Sponsorship and design characteristics of trials registered in ClinicalTrials.gov.
Roumiantseva D; Carini S; Sim I; Wagner TH
Contemp Clin Trials; 2013 Mar; 34(2):348-55. PubMed ID: 23380028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
